lipoic acid
Sponsors
National Center for Complementary and Integrative Health (NCCIH), Oregon Health and Science University, University of Edinburgh, Portland VA Medical Center, VA Office of Research and Development
Conditions
AdrenomyeloneuropathyAllergic RhinitisAlzheimer's DiseaseAsthmaCIDPChronic Inflammatory Demyelinating PolyneuropathyDementiaDiabetes Mellitus, Type 2
Phase 1
Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease
CompletedNCT00090402
Start: 2004-04-30End: 2007-08-31Updated: 2017-07-21
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
CompletedNCT00997438
Start: 2010-08-31End: 2013-12-31Updated: 2017-01-26
Lipoic Acid as a Treatment for Acute Optic Neuritis
CompletedNCT01294176
Start: 2011-01-31End: 2016-11-30Updated: 2019-04-26
Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy
NCT05507697
Start: 2022-05-19End: 2024-05-31Target: 42Updated: 2022-08-19
Phase 2
Antioxidant Functions of Lipoic Acid
CompletedNCT00065624
Start: 2003-11-30End: 2007-07-31Target: 16Updated: 2007-10-02
The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
WithdrawnNCT00398892
Start: 2009-12-31End: 2011-01-31Updated: 2024-05-29
Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
CompletedNCT00962429
Start: 2009-02-28End: 2013-01-31Updated: 2020-08-19
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
CompletedNCT01188811
Start: 2010-10-31End: 2015-08-31Updated: 2017-02-02
Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy
NCT01224353
Start: 2010-11-30End: 2011-07-31Target: 200Updated: 2010-10-21
A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants
CompletedNCT01495260
Start: 2011-09-30End: 2013-11-30Updated: 2019-03-11
Lipoic Acid for Progressive Multiple Sclerosis (MS)
CompletedNCT03161028
Start: 2018-08-17End: 2024-06-30Updated: 2025-03-03